Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteersEvidence for monoaminergic mechanisms

Neuropsychopharmacology

Volumn 20, Issue 4, 1999, Pages 322-339

  Rogers, R D ^a   Everitt, B J ^a   Baldacchino, A ^b   Blackshaw, A J ^c   Swainson, R ^a   Wynne, K ^a   Baker, N B ^a   Hunter, J ^a   Carthy, T ^a   Booker, E ^a   London, M ^b   Deakin, J F W ^c   Sahakian, B J ^a   Robbins, T W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Cambridge ^*  (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Amphetamine; Decision making, 5 HT; Opiates; Orbital prefrontal cortex

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CANNABIS; DEXAMPHETAMINE; OPIATE; TRYPTOPHAN;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOPAMINERGIC SYSTEM; DRUG ABUSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM;

ADULT; AMPHETAMINE-RELATED DISORDERS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; COGNITION; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PREFRONTAL CORTEX; RISK ADJUSTMENT; SEROTONIN; TIME FACTORS; TRYPTOPHAN;

EID: 0032983996     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00091-8     Document Type: Article

References (71)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organisation of functionally segregated circuits linking the basal ganglia and cortex. Annu Rev Neurosci. 9:1986;357-381.
2. Arnsten A.F.T. Catecholamine regulation of the prefrontal cortex. J Psychopharm. 11:1997;151-162.
3. Axt K.J., Molliver M.E. Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse. 9:1991;302-313.
4. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 50:1994;7-15.
5. Bechara A., Tranel D., Damasio H., Damasio A.R. Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex. Cerebral Cortex. 6:1996;215-225.
6. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science. 275:1997;1293-1295.
7. Bechara A., Damasio H., Tranel D., Anderson S.W. Dissociation of working memory from decision-making within human prefrontal cortex. J Neurosci. 18(1):1998;428-437.
8. Bowen F.P., Kamienny M.A., Burns M., Yahr M.D. Parkinsonism. Effects of levodopa on concept formation Neurology. 25:1975;701-704.
9. Brozoski T.J., Brown R., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science. 205:1979;929-931.
10. Cloninger C.R., Bohman M., Sigvardsson S. Inheritance of alcohol abuse. Arch Gen Psychiatry. 38:1981;861-868.
11. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
12. Cloninger C.R. Temperament and personality. Curr Opin Neurobiol. 4:1994;266-273.
13. Damasio AR (1994): Descartes' Error, New York: Grosset/Putnam.
14. Damasio A.R. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Phil Trans R Soc Lond B. 351:1996;1413-1420.
15. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Cippola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci. 11:1991;1907-1917.
16. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci. 85:1988;5274-5278.
17. Downes J.J., Roberts A.C., Sahakian B.J., Evenden J.L., Morris R.G., Robbins T.W. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease. Evidence for a specific attentional dysfunction Neuropsychologia. 27:1989;1329-1343.
18. Eslinger P.J., Damasio A.R. Severe disturbance of higher cognition after bilateral frontal lobe ablation. Patient EVR Neurology. 35:1985;1731-1741.
19. Fishbein D.H., Lozovsky D., Jaffe J.H. Impulsivity, aggression, and neuroendocrine response to serotonergic stimulation in substance abusers. Biol Psychiatry. 25:1988;1049-1066.
20. Freedman M., Oscar-Berman M. Bilateral frontal lobe disease and selective delayed response deficits in humans. Behav Neursci. 100:1996;337-342.
21. Fukui K., Nakajima T., Kariyama H., Kashiba A., Kato N., Tohyama I., Kimura H. Selective reduction of serotonin immunoreactivity in some forebrain regions of rats induced by acute methamphetamine treatment. Quantitative morphometric analysis by serotonin immunocytochemistry Brain Res. 482:1989;198-203.
22. Gibb J.W., Hanson G.R., Johnson M. Neurochemical mechanisms of toxicity. Cho A.K., Segal D.S. Amphetamine and its Analogs. 1994;Academic, San Diego.
23. Groenewegen H.J., Wright C.I., Uylings H.B.M. The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia. J Psychopharm. 11:1997;99-106.
24. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther. 214:1980;257-262.
25. Howell D.C. Statistical Methods for Psychology. 2:1987;Duxbury Press, Boston.
26. Knowlton B.J., Mangels J.A., Squire L.S. A neostriatal habit learning system in humans. Science. 273:1996;1399-1402.
27. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
28. Lacey J.H., Evans C.H.D. The impulsivist. A multi-impulsive personality disorder Br J Addiction. 81:1986;641-649.
29. Lange K.W., Robbins T.W., Marsden C.D., James M., Owen A.M., Paul G.M. L-Dopa withdrawal in Parkinson's disease selectively impairs performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology. 107:1992;394-404.
30. Linnoila M., Virkkunen M., Stein M., Nuptial A., Ripon R., Goodwill F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33:1983;2609-2614.
31. Linnoila M., DeJong J., Virkkunen M. Family history of alcoholism in violent offenders and impulsive fire setters. Arch Gen Psychiatry. 46:1989;613-616.
32. McCown W. Multi-impulsive personality disorder and multiple substance abuse. Evidence from members of self-help groups Br J Addiction. 83:1988;431-432.
33. McGown W. The effect of impulsivity and empathy on abstinence of poly-substance abusers. A prospective study Br J Addiction. 85:1990;635-637.
34. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
35. 18F]fluoro-[sca]1-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse. 22:1996;63-69.
36. Miller L.A. Impulsivity, risk-taking, and the ability to synthesize fragmented information after frontal lobectomy. Neuropsychologia. 30:1992;69-79.
37. Milner B. Some effects of frontal lobectomy in man. Warren J.M., Akert K. The Frontal Granular Cortex and Behavior. 1964;McGraw-Hill, New York.
38. Nace E.P., Saxon J.J., Shore N. A comparison of borderline and nonborderline alcoholic patients. Arch Gen Psychiatry. 40:1983;54-56.
39. Nelson H.E. National Adult Reading Test (NART) Test Manual. 1982;NFER-Nelson, Windsor (UK).
40. Owen A.M., Roberts A.C., Polkey C.E., Sahakian B.J., Robbins T.W. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excision, temporal lobe excision or amygdalo-hippocampectomy in man. Neuropsychologia. 29:1991;993-1006.
41. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 49:1992;975-982.
42. Piazza P.V., Deminierre J.-M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
43. Piazza P.V., Maccari S., Deminierre J.-M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci. 88:1991;2088-2092.
44. Piazza P.V., Deroche V., Deminierre J.-M., Maccari S., Le Moal M., Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties. Implications for sensation-seeking behaviors Proc Natl Acad Sci. 90:1993;11738-11742.
45. Preston K.L., Wagner G.C., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res. 338:1985;243-248.
46. Raleigh M., McGuire M., Melega W., Cherry S., Huang S.-C., Phelps M. Neural mechanisms supporting social decisions in simians. Damasio A.R. Neurobiology of Decision-making. 1996;Heidelberg, Springer-Verlag, Berlin.
47. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain. A regional study Brain Res. 193:1980;153-163.
48. Ricaurte G.A., Schuster C.R., Seiden L.S. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res. 303:1984;359-364.
49. Robbins T.W., Roberts A.C., Owen A.M., Sahakian B.J., Everitt B.J., Muir J., De Salvia M., Tovée M. Monoaminergic-dependent cognitive functions of the prefrontal cortex in monkeys and man. Thierry A.M. Motor and Cognitive Functions of the Prefrontal Cortex. 1994;Heidelberg, Springer-Verlag, Berlin.
50. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis Brain Behav Res. 11:1986;157-198.
51. Ryan L.J., Martone M.E., Linder J.C., Groves P.M. Cocaine, in contrast to d-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular cortex of Long-Evans rats. Life Sci. 43:1988;1403-1409.
52. Ryan L.J., Linder J.C., Martone M.E., Groves P.M. Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res. 518:1990;67-77.
53. Saver J.L., Damasio A.R. Preserved access and processing of social knowledge in a patient with acquired sociopathy due to ventromedial frontal damage. Neuropsychologia. 29:1991;1241-1249.
54. Sawaguchi T., Goldman-Rakic P.S. D1 dopamine receptors in prefrontal cortex. Role in working memory Science. 252:1991;947-950.
55. Seiden L.S., Fischman M.W., Schuster C.R. Long-term methamphetamine induced changes in brain catecholamine in tolerant rhesus monkeys. Drug Alcohol Depend. 1:1975;215-219.
56. Seiden L.S., Ricaurte G.A. Neurotoxicity of methamphetamine and related drugs. Meltzer H. Psychopharmacology. The Third Generation of Progress:1987;Raven Press, New York.
57. Shallice T., Evans M.E. The involvement of the frontal lobes in cognitive estimation. Cortex. 14:1978;294-303.
58. Thierry A.M., Blanc G., Sobel A., Stinus L., Glowinski J. Dopamine terminals in the rat cortex. Science. 182:1973;499-501.
59. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations J Neurosci. 18(1):1998;419-433.
60. Virkkunen M., Rawlings R., Tokola R., Poland R.E., Guidotti A., Nemeroff C., Bissette G., Kalogeras K., Karonen S.L., Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry. 51:1994;20-27.
61. Volkow N.D., Mullani N., Lance Gould K., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users. A study with positron emission tomography Br J Psychiatry. 152:1988;648-651.
62. Volkow N.D., Fowler J.S., Wolf A.P., Hitzemann R., Dewey S.L., Bendreim B., Alpert R., Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 148:1991;621-627.
63. 2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 14:1993;169-177.
64. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 386:1997;830-833.
65. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.
66. Wilson J.M., Norbrega J.N., Carroll M.E., Niznik H.B., Shannak K., Lac S.T., Pristupa Z.B., Dixon L.M., Kish S.J. Heterogenous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci. 14:1991;2966-2979.
67. Wilson J.M., Kalasinksky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human chronic methamphetamine users. Nature Medicine. 2:1996;699-703. a.
68. Wilson J.M., Levey A.I., Bergeron C., Kalasinksky K.S., Lee Ang Peretti F., Adams V.I., Smialek J., Anderson W.R., Shannak K., Deck J., Niznik H.B., Kish S.J. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol. 40:1996;428-439. b.
69. Wise R.A., Rompré P.P. Brain dopamine and reward. Ann Rev Psychol. 40:1989;191-225.
70. Woolverton W.L., Ricaurte G.A., Forno L.S., Seiden L.S. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486:1989;73-78.
71. Young S.N., Smith S.E., Pihl R.O., Ervin F.R. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 87:1985;173-177.